KEYNOTE
Discovering RNA therapeutics with Abzu’s explainable AI
Lykke Pedersen, Head of RNA Therapeutics
Two of the most promising advances in healthcare technology – RNA therapeutics and explainable AI – are fundamentally transforming what’s possible in the field of therapeutic development.
With symbolic regression, heterogenous data (such as sequences and multi-omics data) can effortlessly be integrated, and intricate nonlinear relationships can be revealed – even on wide datasets.
The core technology of Abzu, the QLattice®, is a symbolic regression engine that generates a veritably infinite number of mathematical models to explain fundamental interactions – and yet identifying and understanding interactions is easy with straightforward and simple models.
By using the QLattice, scientists gain a deeper understanding of biological and chemical mechanisms to create new drugs and modalities and increase their success rate, reducing the time required for drug discovery.
Previous image
Next image
Event overview
The BioInnovation Institute (BII) and Benchling hosted a one day, free-to-attend event in Copenhagen that focused on R&D Digital Transformation in Nordic Life Sciences.
The Nordic Digital Science & Innovation Day brought together leading biotech organizations, consultancies, foundations and tech innovators in the region to share the latest trends, innovations and best practices for digitizing R&D assets to accelerate modern science.
